A02 Attachment 2 - Company Product Information - Final 3 Dec 2025.doc

This document is a Company Product Information template (Attachment 2) for a Request for Information (RFI) related to the Battlefield Wound Infection Prevention and Treatment (BWI P&T) program. The RFI (Number HT9427-26-RFI-BWI-PT) seeks information from companies about developing a barrier combination product for wound care in austere battlefield environments. The template requires detailed company information including contact details, business classification, tax identification, CAGE code, UEI number, socio-economic classifications, and capabilities such as having a Federal Supply Schedule contract or an acceptable cost accounting system.

The related federal contract opportunity is being conducted by the Defense Health Agency (DHA) to explore commercial solutions for preventing and treating battlefield wound infections. The program is using a Family of Systems (FoS) approach to develop medical materiel solutions for use across different care roles, from point of injury to hospital settings. Interested parties are required to submit their RFI response electronically by 2:00 PM Eastern on January 20, 2026. The RFI includes three attachments: Technical Readiness Level, Company & Product Information, and Minimum Essential Characteristics, with the goal of identifying potential contractors who can develop innovative wound care and infection prevention products for both military and commercial markets.